Biostate AI closes $12M to bring the Netflix model to molecular diagnostics
Posted:
Biostate AI, a leading innovator in artificial intelligence and RNA sequencing, announced the successful completion of a $12M Series A funding round, led by Accel. The company’s immediate focus is revolutionizing RNAseq accessibility and developing clinically relevant predictive models.
Researchers have begun scanning the first young athletes taking part in a new study using advanced brain imaging to explore the effects of head injuries in 11 to 18-year-olds.
Read more here.
The Swiss company’s over-the-counter wrist wearable, which uses optical sensors to gather blood pressure readings, will be available to U.S. consumers in 2026.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us